Skip to content

Advertisement

  • Research note
  • Open Access

Co-infection of intestinal parasites and Helicobacter pylori among upper gastrointestinal symptomatic adult patients attending Mekanesalem Hospital, northeast Ethiopia

  • 1Email author,
  • 1,
  • 1 and
  • 1
BMC Research Notes201811:144

https://doi.org/10.1186/s13104-018-3246-4

  • Received: 30 October 2017
  • Accepted: 10 February 2018
  • Published:

Abstract

Objective

Intestinal parasites and H. pylori are well-known for their high prevalence worldwide. Thus, the objective of this study waste assess risk factors and co-infection of intestinal parasites and H. pylori among adult patients with upper gastrointestinal complaints. A hospital-based cross sectional study was conducted among 363 consecutive adult patients from December 10, 2015 to February 30,2016. Stool and venous blood were collected for analysis of Intestinal parasites and H. pylori infection, respectively. Data was analyzed using SPSS version 16 and logistic regression analysis was carried out to assess predictors of co-infection. A p ≤ 0.05 was considered as statistically significant.

Results

Helicobacter pylori IgG and intestinal parasites were detected in 70.25–38.3% of participants, respectively while G. lamblia accounted 22.3%. G. lamblia prevalence was significantly higher among H. pylori infected participants (COR: 2.76; 95% CI: 1.46–5.23), but E. hystolytica/dispar infection didn’t show significant variation (p = 0.15). H. pylori and intestinal parasites concomitant co-infection was associated with male sex (AOR: 1.61; 95% CI: 1.01–2.56), consumption of river water (AOR: 1.85; 95% CI: 1.11–3.07) and ground/spring water (AOR: 4.10; 95% CI: 1.97–8.52). Thus, besides H. pylori investigation, upper gastrointestinal symptomatic patients should be screened for G. lamblia infection and other intestinal parasites.

Keywords

  • Co-infection
  • H. pylori
  • G. lamblia
  • Ethiopia

Introduction

Gastrointestinal symptoms are highly prevalent in the general population. Dyspepsia is the most common upper gastrointestinal symptom complex [13] with 25% of the general population suffering from dyspeptic symptoms [4, 5]. The causes of dyspepsia remain uncertain and are likely to be infectious and non-infectious agents. Helicobacter pylori (H. pylori), Giardia lamblia (G. lamblia)]and coeliac disease are common causes of dyspepsia [6]. Recently, polymicrobial causes of upper gastrointestinal disorders have gained tremendous clinical significance, and the importance of synergism has been identified as significant contributor of dyspepsia [7].

It is estimated that H. pylori infects more than 50% of the world population [8] with highest burden among developing countries like those in Africa [9]. G. lamblia has also a worldwide distribution affecting approximately 200 million people globally with 500,000 new cases per year [10]. Besides similar mode of transmission and strong co-relation to socioeconomic levels [11], urease production by H. pylori helps intestinal parasites and bacteria to easily cross the stomach’s acid environment [12].

Besides H. pylori infection, G. lamblia has been found to trigger symptoms of gastrointestinal disorders [13, 14] with dyspepsia reported to be the main symptoms of gastric giardiasis [15]. Similarly, 30% and 15.8–44% of H. pylori and G. lamblia infection, respectively was reported among patients with dyspepsia [6, 11]. Children with gastric complaints showed 65, 10–25% of H. pylori infection, giardiasis and amoebiasis, respectively [16]. In different parts of the world, a potential association between intestinal protozoans and H. pylori infection was documented [6, 17, 18] with 75% prevalence of H. pylori infection among patients with gastric giardiasis [16]. This suggests that health care professionals should be aware of gastric giardiasis as a possible cause of dyspepsia.

In Ethiopia, many studies reported high prevalence of H. pylori infection among dyspeptic patients [1923], but information about rate of intestinal parasites infection is limited. Besides H. pylori infection, it is necessary to assess intestinal parasite infection status of dyspeptic patients to improve their clinical outcome. Therefore, the aim of this study was to assess concomitant co-infection of intestinal parasites and H. pylori, and associated risk factors of adult upper gastrointestinal symptomatic patients at Mekanesalem Hospital.

Main text

Methods

Study patients and setting

This cross-sectional study was conducted at Mekanasalem Hospital from December 10, 2015 to February 30, 2016. It is located in South Wollo zone, Amhara region, northeast Ethiopia. It is the only Hospital in the study area, with 200 beds and different units of both inpatient and outpatients services to the community. The minimum sample size was determined to be 384 by taking 5% marginal error, 95% CI, and 50% prevalence since there was no previous study on the current issue. The study population consisted of adult consecutive outpatients with complaints of one or more upper gastrointestinal symptoms with clinical indications of H. pylori infection.

Inclusion and exclusion criteria

Participants who had at least one of the following upper gastrointestinal complaints such as upper abdominal pain, abdominal bloating, nausea, vomiting, early satiation, post prandial fullness, heartburn, regurgitation, epigastric pain/burning, belching and being volunteer to participate were included. However, patients who were on antibiotic and anti-parasite drugs for 1 week prior to the study involvement, and those with mental problems and patients below 18 years old were excluded.

Data collection

Each study participants were asked to respond to a questionnaire containing sex, age, residence, marital status, education, occupation, and environmental conditions such as water supply and availability of toilet. About 5 ml of venous blood was collected from each participant and serum was separated for serological testing. Thereafter, each participant was given a pre-labeled clean and dry plastic container to collect fresh stool specimen so as to check for intestinal parasites.

Clinical specimen analysis

All collected stool samples were screened for intestinal parasites by using direct wet mount using 0.85% sodium chloride solution as recommended by standard guideline [24]. The blood samples were examined serologically for H. pylori immunoglobulin G (IgG) antibodies using immune chromatographic rapid test kits (dBest H. pylori test kit, Zhejiang, China), which is nationally approved and used for serological diagnosis of H. pylori infection. The manufacturers’ instruction was strictly followed for diagnosis of H. pylori infection.

Statistical analysis

Statistical analysis was performed with SPSS version 16.0. For the descriptive data, frequencies and percentages were used to describe the characteristics of the participants. To assess the association between dependent and independent variables, logistic regression analysis was used. Odds ratios (OR) and 95% confidence intervals (CI) were used to indicate association of the variables. A p ≤ 0.05 was considered statistically significant.

Ethics approval and consent to participate

Research Ethical approval was obtained from the research ethics committee of Wollo University, college of medicine and health sciences, and permission letters was obtained from the hospital management committee. Before commencement of data collection the purpose of the study was explained to the participants and all of them provided written informed consent. Intestinal parasite and H. pylori screening was performed free of charge, and those found to have infection were managed by physicians.

Results

Socio-demographic characteristics

During the study period a total of 363 (57.3% females) with upper gastrointestinal symptomatic adults who fulfilled the inclusion criteria were included in the analysis. The age of participants ranged from 18 to 85 years with a mean (± SD) of 39.11 ± 15.38 years. Majorities, 38.3%, of the participants do not have formal education and 42.1% were farmer. Two hundred eight (57.3%) of total participants were rural residents, and 61.4% of participants had used tap water for their daily consumption. The socio-demographic characteristic of study participants is summarized in Table 1.
Table 1

Socio-demographic characteristics of study participants attending at Mekanesalem Hospital from December 10, 2015 to February30, 2016 (N = 363)

Variable

Frequency

%

Sex

 Male

155

42.7

 Female

208

57.3

Age in years

 ≤ 20

36

9.9

 21–30

103

28.4

 31–40

84

23.1

 41–50

63

17.4

 > 50

77

21.2

Residence

 Urban

155

42.7

 Rural

208

57.3

Marital status

 With partner

234

64.5

 Without partner

129

35.5

Education

 Illiterate

139

38.3

 Primary school (1–8 grade)

72

19.8

 Secondary school (9–12 grade)

64

17.6

 College and above

88

24.2

Occupation

 Farmer

153

42.1

 Student

71

19.6

 House wife

40

11

 Government employee

68

18.7

 Others

31

8.5

Drinking water

 Tap water

223

61.4

 River

104

28.7

 Ground/spring

36

9.9

Availability of toilet

 No

68

18.7

 Yes

295

81.3

Pylori and intestinal parasites co-infection

Among 363 participants, H. pylori IgG and intestinal parasite (IP) were detected in 225 (70.25%) and 139 (38.3%) participants, respectively. G. lamblia accounted 22.3% of isolated parasites. Higher proportion of IP (44.3%) was detected among H. pylori infected participants. Univariate analysis showed statistically significant association between G. lamblia and H. pylori infection (COR = 2.76; 95% CI: 1.46–5.23). However, no significant association observed between E. hystolytica/diaper and H. pylori infection as shown in Table 2.
Table 2

Prevalence of H. pylori and intestinal parasites among study participants attending at Mekanesalem Hospital from December 10, 2015–February 30, 2016

 

Total (%)

H. pylori infection

COR (95% CI)

p value

No, no (%)

Yes, no (%)

Intestinal parasite

 No parasite

224 (61.7)

82 (75.9)

142 (55.7)

1

 

 G. lamblia

81 (22.3)

14 (13)

67 (26.3)

2.76 (1.46–5.23)

0.002*

 E. hystolytica

47 (12.9)

12 (11.1)

35 (13.7)

1.68 (0.83–3.43)

0.15

 A. lumbricoids

4 (1.1)

4 (1.6)

  

 E. vermicularis

7 (1.9)

7 (2.7)

  

 Total

363 (100)

108 (100)

255 (100)

  

* Significant

Univariate analysis showed statistically significant association between gender, residence, type of occupation, educational level, availability of toilet in the home/village, type of water source for daily consumption and H. pylori-IP co-infection. However, clearing the possible confounding factors, a multiple logistic regression model showed statistical significant association between male gender (AOR: 1.61; 95% CI: 1.01–2.56), river water consumption (AOR: 1.85; 95% CI: 1.11–3.07), ground/spring water consumption (AOR:4.10; 95% CI: 1.97–8.52) and H. pylori-IP co-infection (Table 3).
Table 3

Regression analysis showing factors associated with H. pylori-intestinal parasites co-infection

Variables

n

Co-infection

COR (95% CI)

AOR (95% CI)

p value

Yes (%)

Sex

 Female

208

55 (26.4)

1

1

 

 Male

155

57 (36.8)

1.62 (1.03–2.54)

1.61 (1.01–2.56)

0.044*

Residence

 Urban

155

33 (21.3)

1

  

 Rural

208

79 (38.0)

2.26 (1.41–3.64)

 

Marital status

 Without partner

129

45 (34.9)

1

 

 With partner

234

67 (28.6)

0.75 (0.47–1.19)

  

 Gov’t employee

68

14 (20.6)

1

  

Occupation

 Farmer

153

58 (37.9)

2.36 (1.20–4.61)

 

 Student

71

26 (36.6)

2.23 (1.04–4.77)

 

 House wife

40

10 (25.0)

1.29 (0.51–3.25)

 

 Other

31

4 (12.9)

0.57 (0.17–1.90)

 

Education

 Illiterate

139

51 (36.7)

2.10 (1.14–3.89)

 

 Primary (1–8)

72

17 (23.6)

1.12 (0.53–2.36)

 

 Secondary (9–12)

64

25 (39.1)

2.33 (1.14–4.76)

 

 College and above

88

19 (21.6)

1

  

Availability of toilet

 Yes

295

78 (26.4)

1

  

 No

68

34 (50)

2.78 (1.62–4.78)

 

Drinking water

 Tap

223

53 (23.8)

1

1

 

 River

104

39 (37.5)

1.93 (1.17–3.18)

1.85 (1.11–3.07)

0.018*

 Ground/spring

36

20 (55.6)

4.01 (1.94–8.29)

4.10 (1.97–8.52)

0.000*

* Significant

Discussion

Giardia lamblia, E. hystolytica/dispar and H. pylori are considered the most common infectious agents affecting human beings in developing countries [25]. In our study, intestinal parasites were detected in 38.3% of upper gastrointestinal symptomatic patients with G. lamblia (22.3%) being the most prevalent. A similar study conducted in Mexico showed higher (48.4%) prevalence of IP infection with E. histolytica/dispar being the dominant (21.5%) parasite [26]. However, our result is comparable to a study conducted in Sudan where 22% of G. lamblia was detected among patients with gastrointestinal disorder [27].

In this study, high prevalence of IP (44.3%) was observed among H. pylori infected individuals compared to uninfected participants, which is in agreement to a recent report from Ethiopia where IP was significantly associated with H. pylori infection [20]. This is due to urease production by H. pylori that converts urea of the stomach wall to ammonia resulting in increment in stomach pH [28, 29] and allowing intestinal parasites to cross easily and reach to intestine. The possible similar routes of transmission such as the fecal–oral route could also explain the observed high prevalence of IP among H. pylori infected participants in our study.

Even though higher proportion of E. histolytica/dispar was observed among H. pylori infected than uninfected participants, this is not statistically significant. Similar to our result, Moreira et al. showed no significant association between E. histolytica infection and H. pylori sero-positivity [30]. However, Torres et al. showed significantly lower prevalence of H. pylori infection among adults carrying E. histolytica than without E. histolytica [26]. However, this needs well designed cohort type research to ascertain the association.

In our study, we found a significantly higher proportion of giardiasis in participants that also had H. pylori infection as shown in Table 2. Our result is comparable to other studies conducted elsewhere in the world with strong correlation of concomitant G. intestinalis and H. pylori infections [3033]. Recently, Zylberberg et al. in US found that individuals colonized with H. pylori are independently associated with giardiasis [34]. A case control study showed no significant difference in H. pylori and other IP infection, but the combination of H. pylori infection and giardiasis was significantly higher among symptomatic patients compared to controls [18].

However, our result is in contrary to study conducted in Sudan with no statistically significant difference of G. lambliaH. pylori co-infection among H. pylori infected and uninfected participants [27]. This could be due to less sample size of the Sudan study. Moreover, we investigate H. pylori infection using IgG antibody which may not able to detect recent infection. In our study, the large proportion of H. pylori and giardia co-infections could be due to the role of urease produced by H. pylori. It is found a significant increase in urease activity among coinfected (giardiasis and H. pylori) compared to mono (G. lamblia) infected individuals [35]. But it is still vague whether giardiasis increases the susceptibility to H. pylori or not, which warrants further case control cohort and molecular based study.

Our result showed statistical significant association between male gender, river as well as ground/spring water consumption and H. pylori-intestinal parasites co-infection. This agrees with study in Egypt as gender is significantly associated with Giardia and H. pylori co-infection [31]. Furthermore, community based study is needed in this area to identify and clarify the possible risk factors of co-infection.

Conclusion

The present study revealed that 38.3–70.2% of IP and H. pylori infection, respectively, with a strong correlation of concomitant G. lamblia and H. pylori infections. Gender and type of drinking water source was significantly associated with intestinal parasites and H. pylori concomitant co-infection. The observed association requires further study to investigate the observed relationship in more detail, and explanations of this association are required. Besides H. pylori investigation, screening of G. lamblia infection is recommended for successful management of upper gastrointestinal symptomatic patients.

Limitations

The results of this study cannot be representative of the general population due to the following limitations:
  • The cross-sectional nature of the study has limitation to show real correlation of IP and H. pylori infection.

  • H. pylori IgG detection may overestimate the prevalence of H. pylori infection.

  • Direct wet mount preparation may under estimate the prevalence of IP.

  • Prevalence of H. pylori and intestinal parasites coinfection could not be representative of the general population since only upper gastrointestinal symptomatic patients were included in the study.

Abbreviations

AOR: 

adjusted odds ratio

COR: 

crude odds ratio

IgG: 

immunoglobulin G

IP: 

intestinal parasite

OR: 

odds ratio

Declarations

Authors’ contributions

AS: performed the design of the study, data acquisition and management, study supervision, analysis, interpretation of data and manuscript preparation. ZT: study design, supervision, data acquisition, critical review of the manuscript; BK: study design, acquisition of data; MS: study design, acquisition of data. All authors have edited the final manuscript for publication. All authors read and approved the final manuscript.

Acknowledgements

We would like to thank all the study participants, the data collectors and the laboratory technicians who participated in the research work. Our special thanks also go to Mekanesalem Hospital administration for its unreserved support during the data collection.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The authors confirm that all data underlying the findings are fully available without restriction. The corresponding author is responsible to be contacted and justify any question regarding to the result. All relevant data are within the manuscript.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Research ethical approval was obtained from the research ethics committee of Wollo University, college of medicine and health sciences, and permission letters was obtained from the hospital management committee. Before commencement of data collection the purpose of the study was explained to the participants and all of them provided written informed consent. Intestinal parasite and H. pylori screening was performed free of charge, and those found to have infection were managed by physicians.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Po. Box 1145, Dessie, Ethiopia

References

  1. Wallander MA, Johansson S, Ruigomez A, Garcia Rodriguez LA, Jones R. Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract. 2007;24:403–11.View ArticlePubMedGoogle Scholar
  2. Tack J, Talley NJ, Camilleri M, Holtmann G, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–79.View ArticlePubMedGoogle Scholar
  3. Tepeš B. Subgroups of dyspepsia. In: Duvnjak M, editor. Dyspepsia in clinical practice. Berlin: Springer; 2011. p. 9–18.Google Scholar
  4. Hasan M. Dyspepsia in primary care practice in Bangladesh. Bangladesh Med J. 2013;42(2):63–9.Google Scholar
  5. Yazdanpanah K, Moghimi N, Yousefinejad V, Ghaderi E, Azizi A, Nazem SF. Dyspepsia prevalence in general population aged over 20 in the west part of Iran. J Pak Med Assoc. 2012;62(7):672–6.PubMedGoogle Scholar
  6. Fouad SA, Esmat S, BasyoniMaha MA, Salah Farhan M, Kobaisi MH. Molecular identification of Giardia intestinalis in patients with Dyspepsia. Digestion. 2014;90:63–71. https://doi.org/10.1159/000362644.View ArticlePubMedGoogle Scholar
  7. Brogden KA, Guthmiller JM, Taylor CE. Human polymicrobial infections. Lancet. 2005;365:253–5.View ArticlePubMedGoogle Scholar
  8. World Gastroenterology Organization Global Guideline. Helicobacter pylori in developing countries. J Dig Dis. 2011;12:319–26.View ArticleGoogle Scholar
  9. Olokoba A, Gashau W, Bwala S, Adamu A, Salawu FK. Helicobacter pylori infection in Nigerians with dyspepsia. Ghana Med J. 2013;47(2):79–81.PubMedPubMed CentralGoogle Scholar
  10. Ivanov AI. Giardia and giardiasis. Bulgarian J Vet Med. 2010;13(2):65–80.Google Scholar
  11. Yakoob J, Jafari W, Abid S, Tafari N, Hamid S, Shah HA, Rizvi L, Islam M, Shaikh H. Giardiasis in patient with dyspeptic symptoms. World J Gastra enteral. 2005;11(42):6667–66705.View ArticleGoogle Scholar
  12. David TJ, William AP, Markell EK, Vege S. Medical parasitology, vol. 9. New York: Saunders Elsevier; 2006.Google Scholar
  13. Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol. 2009;9:27. https://doi.org/10.1186/1471-230X-9-27.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Guarnieri G, Spiniello E. Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study. World J Gastroenterol. 2006;12:1941–4.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Sanad MM, Darwish RA, Nasr ME, El-Gammal NE, Emara MW. Giardia lamblia and chronic gastritis. J Egypt Soc Parasitol. 1996;26(2):481–95.PubMedGoogle Scholar
  16. Bin Mohanna MA, Al-Zubairi LM, Sallam AK. Prevalence of Helicobacter pylori and parasites in symptomatic children examined for Helicobacter pylori antibodies, antigens, and parasites in Yemen. Saudi Med J. 2014;35(11):1408–11.PubMedPubMed CentralGoogle Scholar
  17. Kazemian H, Shavalipour A, Mohebi R, Ghafurian S, Aslani S, Maleki A, Kardan J, Hiedari H, Sadeghifard N. Estimation of the parasitic infection prevalence in children with Helicobacter pylori infection in Ilam City (2012–2013). Arch Pediatr Infect Dis. 2014. https://doi.org/10.5812/pedinfect.15294.Google Scholar
  18. Zeyrek D, Zeyrek F, Cakmak A, Cekin A. Association of Helicobacter pylori and giardiasis in children with recurrent abdominal pain. Türkiye Parazitol Derg. 2008;32(1):4–7.PubMedGoogle Scholar
  19. Asrat D, Nilsson I, Mengistu Y, et al. Prevalence of Helicobacter pylori infection among adult dyspeptic patients in Ethiopia. Trop Med Parasitol. 2004;98:181–9.View ArticleGoogle Scholar
  20. Kibru D, Gelaw B, Alemu A, Addis Z. Helicobacter pylori infection and its association with anemia among adult dyspeptic patients attending Butajira Hospital, Ethiopia. BMC Infect Dis. 2014;14:656. https://doi.org/10.1186/s12879-014-0656-3.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Tesfahun T, Yohannes M, Kassu D, Daniel A. Seroprevalence of Helicobacter pylori infection in and its relationship with ABO blood groups. Ethiop J Health Dev. 2005;19(1):55–9.Google Scholar
  22. Moges F, Kassu A, Mengestu G, et al. Seroprevalence in dyspeptic patients and its relationship with HIV infection, ABO blood group and life style in a university hospital, north west Ethiopia. World J Gastroenterol. 2006;12:1957–61.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Wubejig A, Mulugeta K, Bayeh A. Prevalence and risk factors of H. pylori from dyspeptic patients in northwest Ethiopia: a hospital based cross-sectional study. Asian Pac J Cancer Prev. 2014;15(11):55–9.Google Scholar
  24. Chesbrough M. Medical laboratory manual for tropical countries. Vol. II: Microbiology tropical health. Technology/butter worths and co. Ltd: Cambridge/Sevenaks; 2006.Google Scholar
  25. Sabet EA, El-hadi HA, Mohamed DS, Sheneef A, Fattouh M, Esmat MM. “Gastritis; Helicobacter pylori or Giardia lamblia infection or both”. Egyptian J Med Microbiol. 2009;18(4):165–78.Google Scholar
  26. Torres J, Perez Perez G, Ximenez C, Muñoz L, Camorlinga-Ponce M, Ramos F, Gomez A, Muñoz O. The association of intestinal parasitosis and H. Pylori infection in children and adults from a Mexican community with high prevalence of parasitosis. Helicobacter. 2003;8(3):179–85.View ArticlePubMedGoogle Scholar
  27. Ahmed NFM, Elfaki TEM, Elsayid M. Prevalence rate of Giardia lamblia/Helicobacter Pylori co-infections in Khartoum State, Sudan. Int J Sci Technol Res. 2016;5(3):181–90.Google Scholar
  28. Kuster JG, Vanviret AH, Kulpers EJ. Pathogenisis of H. pylori infections. Clin Microbiol Rev. 2006;19(3):449–90.View ArticleGoogle Scholar
  29. Boyanova L, Mitov I, Vladimirov B. Epidemiology of H. pylori infection. USA: Caister Academic press Univ of Kanasas; 2011. p. 84–94.Google Scholar
  30. Moreira ED Jr, Nassri VB, Santos RS, Matos JF, De Carvalho WA, Silvani CS, Sant’Ana CS. Association of Helicobacter pylori infection and giardiasis: results from a study of surrogate markers for fecal exposure among children. World J Gastroenterol. 2005;11(18):2759–63.View ArticlePubMedGoogle Scholar
  31. El-badry AA, Ghieth M, Ahmed DA, Ismail MA. Giardia intestinalis and helicobacter pylori co-infection: estimated risks and predictive factors in egypt. J Egypt Soc Parasitol. 2017;47(1):19–24.Google Scholar
  32. Ankarklev J, Hestvik E, Lebbad M, Lindh J, Kaddu-Mulindwa DH, et al. Common coinfections of Giardia intestinalis and Helicobacter pylori in non-symptomatic Ugandan children. PLoS Negl Trop Dis. 2012;6(8):e1780. https://doi.org/10.1371/journal.pntd.0001780.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Dogliani C, De Boni M, Cielo R, Laurino L, Pelosio P, Braidotti P, Viale G. Gastric giardiasis. J Clin Pathol. 1992;45(11):964–7.View ArticleGoogle Scholar
  34. Zylberberg HM, Green PH, Turner KO, Genta RM, Lebwohl B. Prevalence and predictors of giardia in the united states. Dig Dis Sci. 2017;62(2):432–40.View ArticlePubMedGoogle Scholar
  35. Abou El-Hoda MM, Osman HM, Rasha MM, Douidar NL, Enany AY. Impact of Helicobacter pylori infection on the activities of urease and lipase enzymes in patients with giardiasis. J Egypt Public Health Assoc. 2007;82(3–4):273–82.PubMedGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement